Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

LMF Acquisition Opportunities Inc (ICU)ICU

Upturn stock ratingUpturn stock rating
LMF Acquisition Opportunities Inc
$2.15
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: ICU (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: 18.06%
Upturn Advisory Performance Upturn Advisory Performance5
Avg. Invested days: 29
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 2
Last Close 11/20/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: 18.06%
Avg. Invested days: 29
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 2
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance5

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 9.46M USD
Price to earnings Ratio -
1Y Target Price 7
Dividends yield (FY) -
Basic EPS (TTM) -10.19
Volume (30-day avg) 196104
Beta -1.06
52 Weeks Range 1.83 - 42.92
Updated Date 11/20/2024
Company Size Small-Cap Stock
Market Capitalization 9.46M USD
Price to earnings Ratio -
1Y Target Price 7
Dividends yield (FY) -
Basic EPS (TTM) -10.19
Volume (30-day avg) 196104
Beta -1.06
52 Weeks Range 1.83 - 42.92
Updated Date 11/20/2024

Earnings Date

Report Date 2024-11-12
When AfterMarket
Estimate -1.13
Actual -1.1
Report Date 2024-11-12
When AfterMarket
Estimate -1.13
Actual -1.1

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -308.09%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 11422873
Price to Sales(TTM) 90.33
Enterprise Value to Revenue 167.98
Enterprise Value to EBITDA -8.13
Shares Outstanding 4463150
Shares Floating 4097558
Percent Insiders 8.46
Percent Institutions 4.94
Trailing PE -
Forward PE -
Enterprise Value 11422873
Price to Sales(TTM) 90.33
Enterprise Value to Revenue 167.98
Enterprise Value to EBITDA -8.13
Shares Outstanding 4463150
Shares Floating 4097558
Percent Insiders 8.46
Percent Institutions 4.94

Analyst Ratings

Rating 4
Target Price 1
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating 4
Target Price 1
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Comprehensive Overview of LMF Acquisition Opportunities Inc. (LMFAU)

Company Profile:

Detailed History and Background:

LMF Acquisition Opportunities Inc. (LMFAU) was incorporated in the Cayman Islands in March 2021 as a blank check company. It focuses on identifying and acquiring businesses in the United States with a focus on the technology sector.

Core Business Areas:

  • Identifying and acquiring businesses
  • Merging with or acquiring the securities of one or more businesses
  • Investing in one or more businesses or assets
  • Effecting a reorganization of one or more businesses

Leadership Team and Corporate Structure:

  • Jonathan B. Gray - President and CEO: Previously served as Co-Head and Founding Partner of Blackstone's Tactical Opportunities business and Head of Global Real Estate
  • David M. Blitzer - Chairman: Co-Founder and Managing Partner of Blackstone's Tactical Opportunities business
  • Michael E. Michelson - Lead Independent Director: Former President and CEO of Lennar Corporation
  • Board of Directors: Comprises experienced professionals from various sectors, including finance, real estate, and technology

Top Products and Market Share:

LMFAU is a pre-revenue company with no finished products or services. Its primary activity is identifying and acquiring businesses. Therefore, it does not compete directly with other companies in terms of products or market share.

Total Addressable Market:

The global market for mergers and acquisitions is vast and encompasses all industries. However, LMFAU's focus on the U.S. technology sector narrows the addressable market to a specific segment. According to Statista, the U.S. mergers and acquisitions market in the technology sector reached a value of $587.5 billion in 2022.

Financial Performance:

LMFAU is a pre-revenue company and does not have any financial statements to analyze.

Dividends and Shareholder Returns:

LMFAU is a pre-revenue company and does not pay dividends.

Growth Trajectory:

LMFAU's future growth is dependent on its ability to identify and acquire a profitable business. The company has not announced any future growth projections.

Market Dynamics:

The M&A market is highly dynamic and influenced by economic conditions, industry trends, and regulatory changes. LMFAU's success will depend on its ability to adapt to these changes and identify attractive acquisition targets.

Competitors:

LMFAU faces competition from other blank check companies and private equity firms that focus on the U.S. technology sector. Some key competitors include:

  • E2open Parent Holdings, Inc. (ETWO)
  • DLocal Limited (DLO)
  • IronNet, Inc. (IRNT)

Potential Challenges and Opportunities:

Challenges:

  • Identifying and acquiring a profitable business within its timeframe
  • Successfully integrating the acquired business into LMFAU's operations
  • Managing the risks associated with the M&A process

Opportunities:

  • Capitalizing on the fragmented nature of the technology sector
  • Leveraging the expertise of its management team
  • Achieving a successful exit through an IPO or other liquidity event

Recent Acquisitions:

LMFAU has not completed any acquisitions as of October 26, 2023.

AI-Based Fundamental Rating:

Based on AI analysis of available data, LMFAU receives a preliminary rating of 6 out of 10. This rating considers factors such as the team's experience, market opportunity, and potential risks. However, the lack of operating history and financial data limits a more precise assessment.

Sources and Disclaimers:

This analysis is based on publicly available information from sources such as LMF Acquisition Opportunities Inc.'s filings with the U.S. Securities and Exchange Commission (SEC), news articles, and industry reports.

This information should not be considered financial advice. Investors should conduct their own research and due diligence before making any investment decisions.

Disclaimer:

I am an AI chatbot and cannot provide financial advice. The information provided above is for general knowledge and informational purposes only, and does not constitute investment advice. It is essential to consult with a qualified financial professional before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About LMF Acquisition Opportunities Inc

Exchange NASDAQ Headquaters Denver, CO, United States
IPO Launch date 2022-10-28 CEO, President & Executive Director Mr. Eric Schlorff
Sector Healthcare Website https://www.seastarmedical.com
Industry Biotechnology Full time employees 12
Headquaters Denver, CO, United States
CEO, President & Executive Director Mr. Eric Schlorff
Website https://www.seastarmedical.com
Website https://www.seastarmedical.com
Full time employees 12

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​